Proposed
Bill · 119th Congress · S 4066
Safeguarding Women from Chemical Abortion Act
Refreshed 3 h ago
Introduced 2026-03-11Topic: health care · public health · civil rightsSummary
AI-generated summary, report an errorThis bill would treat the federal approval of the drug mifepristone for ending a pregnancy, and approvals of generic versions for the same use, as withdrawn 14 days after the bill becomes law. After that, shipping the drug across state lines for that use would violate federal drug law, and mifepristone labeled for ending a pregnancy would be considered misbranded. The bill would also make manufacturers of mifepristone liable to people who suffer physical or mental health harm linked in whole or in part to using the drug. Those people could sue in federal or state court for compensatory damages, punitive damages, and attorney's fees, starting 90 days after the bill becomes law.
Sponsors
- Josh Hawley Republican sponsor
- 7 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2026-03-11 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | refer |
| 2026-03-11 | Introduced in Senate | introduce |